Balchem Corporation (BCPC)
NASDAQ: BCPCIndustrialsMajor ChemicalsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
BCPC stock chart
Technical analysisKey statistics
All statistics- Market cap
- $5.20B
- P/E (TTM)
- 30.86
- Forward P/E
- 25.70
- EPS (TTM)
- $5.30
- Dividend yield
- 0.59% ($0.96)
- Ex-dividend date
- Dec 23, 2025
- 52-week range
- 147.18 – 186.15
- Day range
- 162.90 – 167.91
- Volume / Avg
- 237.74K / 252.38K
- Beta
- —
- Shares outstanding
- 31.78M
52-week range
BCPC stock today
Shares of Balchem (BCPC) finished lower on Nov 20 at $163.54, a drop of 1.21% or $2.00 per share, versus the S&P 500's 3.70% decline. At this level, BCPC sits in the middle of its 52-week range of $147.18 to $186.15: 12.1% below the high, set on Nov 5, 2026 and 11.1% above the low. BCPC is up 6.6% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 5.2%.
At 30.9x trailing earnings, Balchem trades above the peer-group median of 25.3x. Its forward P/E of 25.7x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. Balchem pays an annual dividend of $0.96 per share, a 0.59% yield at the current price.
Summary generated from market data by MetaCap's automated system. Methodology
About Balchem
Company profileBalchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry.
- Sector
- Industrials
- Industry
- Major Chemicals
- CEO
- Mr. Theodore Lee Harris
- Headquarters
- Montvale, NJ
- Employees
- 1,430
- Website
- balchem.com
Financial highlights
Full financialsIn fiscal 2025, Balchem generated $1.04 billion in revenue, up 8.8% from fiscal 2024, its 2nd consecutive year of revenue growth. Net income was $154.8 million (+20.5% year over year), for a net margin of 14.9% versus a median of 12.0% in the prior 5 years. Gross margin was 35.7% (up from 35.3%) and operating margin 20.2%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $1.04B | $953.68M | $922.44M | $942.36M | $799.02M |
| Growth | +8.75% | +3.39% | -2.11% | +17.94% | +13.56% |
| Net income | $154.84M | $128.47M | $108.54M | $105.37M | $96.10M |
| EPS (diluted) | $4.75 | $3.93 | $3.35 | $3.25 | $2.94 |
Analyst forecast
ForecastConsensus (3 analysts)
none
Avg. price target
$213.50+30.55%
- Strong buy 1
- Buy 1
- Hold 1
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Oct 23, 2026
- EPS actual vs est.
- $1.35 vs $1.54
- Surprise
- -12.34%
Dividends
Dividend history- Annual dividend
- $0.96
- Dividend yield
- 0.59%
- Last payment
- $0.96
- Ex-dividend date
- Dec 23, 2025
BCPC news
All BCPC news- Balchem: 3 Key Takeaways for Long-Term InvestorsNasdaq
- Balchem (BCPC) Q3 2026 Earnings Call TranscriptNasdaq
- Balchem signals 22.5%-23% tax rate range while planning new sports partnership announcementSeeking Alpha
- Balchem Corporation Reports Third Quarter 2026 net sales of $290.7 million and net earnings of $46.7 millionNasdaqBCPC, SUN
- Balchem Corp. Q3 Income RisesNasdaq
- Balchem Non-GAAP EPS of $1.57 beats by $0.04, revenue of $290.7M beats by $1.45MSeeking Alpha
- Balchem Corporation Reports Third Quarter 2026 Financial ResultsGlobeNewswire
- Balchem Q3 2026 Earnings PreviewSeeking Alpha
Balchem peers
Industrials sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| HXLHexcel Corporation | 72.92 | -4.17% | $5.52B | vs BCPC |
| CECelanese Corporation | 45.01 | -5.04% | $4.94B | vs BCPC |
| SXTSensient Technologies Corporation | 113.85 | -2.22% | $4.85B | vs BCPC |
| MEOHMethanex Corporation | 61.18 | -3.01% | $4.73B | vs BCPC |
| VVVValvoline Inc. | 36.25 | -1.60% | $4.62B | vs BCPC |
| PRMPerimeter Group Inc. | 27.55 | -5.97% | $4.51B | vs BCPC |
| NEUNewMarket Corp | 697.47 | -2.65% | $6.41B | vs BCPC |
| AVNTAvient Corporation | 42.84 | -1.13% | $3.93B | vs BCPC |
Indexes, lists and sector
Balchem stock FAQ
What is Balchem's stock price today?
BCPC last traded at $163.54 as of Nov 20, 4:00 PM EST, down 1.21% on the day. Prices are delayed at least 15 minutes.
Does Balchem pay a dividend?
Yes. Balchem pays $0.96 per share annually, a 0.59% yield. The most recent dividend of $0.96 had an ex-dividend date of Dec 23, 2025.
What is BCPC's P/E ratio?
BCPC trades at a trailing P/E ratio of 30.86 and a forward P/E of 25.70, compared with a median of 25.3 for its closest peers.
Who is Balchem's CEO?
Mr. Theodore Lee Harris is the chief executive officer of Balchem Corporation, which has about 1,430 employees.
Has BCPC ever split its stock?
Yes. The most recent BCPC stock split was a 3-for-2 split on Jan 21, 2010, one of 8 splits on record.
What is the BCPC 52-week high?
The 52-week high for BCPC is $186.15 and the 52-week low is $147.18. The stock is currently 12.1% below its high.